Lv21
118 积分 2025-02-25 加入
Asiaticoside alleviates metabolic associated fatty liver disease via PI3K/AKT/mTOR signaling pathway
5小时前
求助中
FTO/m6A/GPNMB axis: a novel promising target for hepatocellular carcinoma (HCC) treatment?
2个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
6个月前
已完结
Dysregulation of autophagy in melanocytes contributes to hypopigmented macules in tuberous sclerosis complex
6个月前
已完结
Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism
6个月前
已完结
Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism
6个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
7个月前
已完结
hiPSC‐derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver
7个月前
已完结
P18-26 Development of CYP1A1-mCherry hiPSC-derived hepatic organoids for enhanced sensitivity to AHR agonists
7个月前
已关闭
Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism
7个月前
已完结
皖公网安备34019202002308
